Literature DB >> 15792612

The idiosyncratic relationship between diagnostic delay and stage of oral squamous cell carcinoma.

S E Scott1, E A Grunfeld, M McGurk.   

Abstract

Approximately half of patients with oral cancer present with advanced lesions when five-year survival rates are as low as 20%, however, diagnostic delay has repeatedly been found to be unrelated to the stage of oral cancer at diagnosis. The aim of this study was to investigate why diagnostic delay is frequently unrelated to the stage of oral cancer at diagnosis. The odds ratio (OR) of early versus advanced oral squamous cell carcinoma was calculated for 245 consecutive patients with untreated oral squamous cell carcinoma. Being female (OR=0.40; 0.19-0.80; p<0.05) and married (OR=0.27; 0.11-0.66; p<0.01) was predictive of early stage disease. Being non-white (OR=5.42; 1.66-17.67; p<0.01) was predictive of advanced stage disease. There is no evidence that these patient demographics are associated with faster growing tumours, yet it is possible that those who are male, unmarried and non-white may not notice an oral lesion until it is advanced in stage. It is concluded that differences in tumour biology are not a likely explanation for the absence of a delay-stage relationship but instead, a proportion of tumours may be silent until advanced in stage.

Entities:  

Mesh:

Year:  2005        PMID: 15792612     DOI: 10.1016/j.oraloncology.2004.10.010

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  22 in total

Review 1.  Advances in fluorescence imaging techniques to detect oral cancer and its precursors.

Authors:  Dongsuk Shin; Nadarajah Vigneswaran; Ann Gillenwater; Rebecca Richards-Kortum
Journal:  Future Oncol       Date:  2010-07       Impact factor: 3.404

2.  Terahertz imaging of excised oral cancer at frozen temperature.

Authors:  Yookyeong Carolyn Sim; Jae Yeon Park; Kang-Min Ahn; Chansik Park; Joo-Hiuk Son
Journal:  Biomed Opt Express       Date:  2013-07-23       Impact factor: 3.732

3.  Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis.

Authors:  Antonieta Medina-Lara; Bogdan Grigore; Ruth Lewis; Jaime Peters; Sarah Price; Paolo Landa; Sophie Robinson; Richard Neal; William Hamilton; Anne E Spencer
Journal:  Health Technol Assess       Date:  2020-11       Impact factor: 4.014

4.  Circular GOLPH3 RNA exerts oncogenic effects in vitro by regulating the miRNA-1299/LIF axis in oral squamous cell carcinoma.

Authors:  Chen Zou; Xia Li; Haigang Wei; Siyuan Wu; Jing Song; Zhe Tang; Hailing Luo; Xiaozhi Lv; Yilong Ai
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

5.  Diagnosis and referral delays in primary care for oral squamous cell cancer: a systematic review.

Authors:  Ciaran Grafton-Clarke; Kai Wen Chen; Jane Wilcock
Journal:  Br J Gen Pract       Date:  2018-11-19       Impact factor: 5.386

6.  Epidemiological study of malignant tumors in the oral and maxillofacial region: survey of member institutions of the Japanese Society of Oral and Maxillofacial Surgeons, 2002.

Authors:  Yasunori Ariyoshi; Masashi Shimahara; Ken Omura; Etsuhide Yamamoto; Harumi Mizuki; Hiroshige Chiba; Yutaka Imai; Shigeyuki Fujita; Masanori Shinohara; Kanichi Seto
Journal:  Int J Clin Oncol       Date:  2008-06-14       Impact factor: 3.402

Review 7.  Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review.

Authors:  R D Neal; P Tharmanathan; B France; N U Din; S Cotton; J Fallon-Ferguson; W Hamilton; A Hendry; M Hendry; R Lewis; U Macleod; E D Mitchell; M Pickett; T Rai; K Shaw; N Stuart; M L Tørring; C Wilkinson; B Williams; N Williams; J Emery
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

8.  MicroRNA-196a-5p is a potential prognostic marker of delayed lymph node metastasis in early-stage tongue squamous cell carcinoma.

Authors:  Tessho Maruyama; Kazuhide Nishihara; Masato Umikawa; Akira Arasaki; Toshiyuki Nakasone; Fumikazu Nimura; Akira Matayoshi; Kimiko Takei; Saori Nakachi; Ken-Ichi Kariya; Naoki Yoshimi
Journal:  Oncol Lett       Date:  2017-12-08       Impact factor: 2.967

9.  Are we able to reduce the mortality and morbidity of oral cancer; some considerations.

Authors:  Isaäc van der Waal
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-01-01

10.  Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders.

Authors:  Yen-Yun Wang; Yen-Hsuan Tail; Wen-Chen Wang; Ching-Yi Chen; Yu-Hsun Kao; Yuk-Kwan Chen; Chung-Ho Chen
Journal:  BMC Oral Health       Date:  2014-08-05       Impact factor: 2.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.